Thursday, September 16, 2020
6:00 pm - 7:30 pm

Hope Auditorium, Yale University School of Medicine
315 Cedar Street, New Haven

Please RSVP to [email protected]

Creating a Successful Medical Device Enterprise

A Presentation by Al Mann
Followed by networking, refreshments & wine bar

Alfred E. Mann has founded and largely funded 17 companies in his career. Nine were acquired at an overall total of almost $8 billion, and two became public companies.

He is currently chairman and CEO of MannKind Corporation. Its lead investigational product candidate, AFREZZA™, is an ultra rapid-acting insulin. The facility constructed in Danbury, CT for the commercial production of AFREZZA™ has won numerous accolades, including the CURE 2010 New Operations Award and Facility of the Year awards for process and equipment innovation from ISPE/INTERPHEX.

Mr. Mann was also the founder and/or holds positions with Bioness, which develops and manufactures systems to address neural deficits and to restore controlled function or paralyzed limbs; Second Sight, which is developing a visual prosthesis to restore sight to the blind; IncuMed, which is developing novel percutaneous seals for various applications; PerQFlo, which is developing drug delivery systems; Quallion, which develops, manufactures, and markets advanced batteries for medical, aerospace, and military applications; Stellar Microelectronics, which produces micro-circuit assemblies; and Round Trip, which is developing location and identification technology.

Mr. Mann has established Alfred Mann Institutes at several universities to serve as business incubators, and the Alfred Mann Foundation, a nonprofit research organization devoted to development of advaced medical products in a variety of fields.

Born in Portland, OR in 1925 and raised there, Mr. Mann moved to Los Angeles in 1946. He receive his BS and MS in physics from UCLA. In 1956 he founded the first of two aerospace companies that are now part of the Boeing Company.

He was founder in 1972 of Pacesetter Systems, which was acquired by Siemens in 1985; its successor company is now part of St. Jude Medical. He founded MiniMed, which develops microinfusion and continuous glucose monitoring systems that have revolutionized the treatment of Type 1 diabetes, and Medical Research Group, which was developing an artificial pancreas. Both companies are now part of Medtronic. He was also the founder of Advanced Bionics in 1993, a cochlear implant business that was acquired by Boston Scientific in 2004 and is now part of Sonova.

The BioHaven Entrepreneurship Series features presentations designed to showcase regionally developed life science technologies that have progressed along the path to commercialization.  Speakers at the BioHaven events represent both the scientific and business side of the enterprises.

The programs focus on key success factors of each company, scientific or technological advantage, business model, and lessons learned in starting and developing the business. The series also provides social networking opportunities for scientists, researchers, and businessmen.

Speakers